HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Response to rituximab in B-CLL patients is adversely impacted by frequency of IL-10 competent B cells and FcγRIIIa polymorphism. A study of FCGCLL/WM and GOELAMS groups

Document type :
Journal articles
Complete list of metadata

Cited literature [11 references]  Display  Hide  Download

https://hal.univ-lorraine.fr/hal-01666834
Contributor : Ngere Ul Connect in order to contact the contributor
Submitted on : Monday, February 3, 2020 - 4:42:29 PM
Last modification on : Thursday, March 17, 2022 - 9:47:53 AM

File

Response to rituximab in B-CLL...
Publisher files allowed on an open archive

Licence


Distributed under a Creative Commons Attribution 4.0 International License

Identifiers

Citation

Anne-Laure Gagez, Émilie Tuaillon, R Cezar, Caroline Dartigeas, B Mahé, et al.. Response to rituximab in B-CLL patients is adversely impacted by frequency of IL-10 competent B cells and FcγRIIIa polymorphism. A study of FCGCLL/WM and GOELAMS groups. Blood Cancer Journal, Nature Publishing Group, 2016, 6 (1), pp.e389. ⟨10.1038/bcj.2015.115⟩. ⟨hal-01666834⟩

Share

Metrics

Record views

248

Files downloads

101